| Description: |
Tissue polypeptide specific antigen was first identified as
a tumour marker in the late 1950’s, and has recently been
shown to be closely related to human cytokeratin 18.
Cytokeratins are a group of about 20 cytoskeletal
proteins, whose degradation gives rise to soluble
fragments, measurable in the blood of patients. Serum
levels are high in breast cancer patients and also some
other malignancies, probably due to high cell turnover in
tumours. RANDOX recombinant human CK-18 is expressed in E.
coli with an amino-terminal hexahistidine tag. This product
is for research use only and is not intended for diagnostic
or therapeutic use
|
| Application:
|
ELISA, Western Blot, Dot Blot, Immunohistology chemistry, Immunoassays, Development of Rapid tests and other immunoassay,
|
| Buffer:
|
Carrier free format presented in 50% glycerol buffered with saline or Tris
|
| Form:
|
Liquid.
|
| Molecular Weight:
|
51.6 kDa
|
| Purity:
|
>95% by SDS-PAGE
|
| Storage:
|
≤-20°C
|
| References:
|
D'Alessandro, R. et al. (2001) Breast Cancer Res. Treat.
68(1): 9-19.
|
| Datasheet: |
|
